Condition: Colonic Neoplasms · Neoplasms, Colon · Sponsor: GlaxoSmithKline
The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon cancer.
This description comes directly from the study's public registry record.
US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com
EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com
Always discuss trial participation with your own doctor first.
| GSK Investigational Site | Tucson, Arizona, United States | Recruiting |
| GSK Investigational Site | Los Angeles, California, United States | Recruiting |
| GSK Investigational Site | New Haven, Connecticut, United States | Recruiting |
| GSK Investigational Site | Washington D.C., District of Columbia, United States | Withdrawn |
| GSK Investigational Site | Deerfield Beach, Florida, United States | Withdrawn |
| GSK Investigational Site | Fort Lauderdale, Florida, United States | Withdrawn |
| GSK Investigational Site | Marietta, Georgia, United States | Withdrawn |
| GSK Investigational Site | Chicago, Illinois, United States | Recruiting |
| GSK Investigational Site | Chicago, Illinois, United States | Recruiting |
| GSK Investigational Site | Chicago, Illinois, United States | Withdrawn |
| GSK Investigational Site | Naperville, Illinois, United States | Recruiting |
| GSK Investigational Site | Naperville, Illinois, United States | Recruiting |
+ 254 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05855200